3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, B-Cell
5
Leukemia, Myeloid, Acute
5
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Glioblastoma
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Triple Negative Breast Neoplasms
2
Sarcoma, Synovial
2
Ovarian Neoplasms
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Fallopian Tube Neoplasms
2
Burkitt Lymphoma
2
Astrocytoma
2
Osteosarcoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Liposarcoma, Myxoid
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Lymphoid
1
Leukemia, B-Cell
1
Leukemia
1
Interventions
Dexamethasone
3
daratumumab
2
Lenalidomide
2
pomalidomide
1
navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
cc-486
1
carfilzomib
1
auricularum
1
Specimen Handling
1
Radiotherapy
1
Immunotherapy, Adoptive
1
Calcium Dobesilate
1
Bortezomib
1
Biopsy
1
2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Plasmacytoma
×
Leukapheresis
×
1 year
×
Clear all
No trials found.